David Gene Morgan
Research Subjects
David Gene Morgan has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Ayesha Amjad
Department of Chemistry
1 shared publication- Bogdan Dragnea
Department of Chemistry, Indiana University, Bloomington, Indiana 47405, United States
1 shared publication - Irina B. Tsvetkova
Department of Chemistry, Indiana University, Bloomington, Indiana 47405, United States
1 shared publication - Jack S. Googasian
Department of Chemistry, Indiana University – Bloomington, 800 E Kirkwood Ave, Bloomington, IN 47405, USA
1 shared publication - Jette Katja Mathiesen
Fritz Haber Institute of the Max Planck Society
1 shared publication - Kirsten Marie Ørnsbjerg Jensen
Department of Chemistry, University of Copenhagen, Universitetsparken 5, Copenhagen, Denmark, 2100
1 shared publication
Latest Publications
- 29 December 2025
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (7) , 5438-5451
An Assembly-Line Mechanism for In Vitro Encapsulation of Fragmented Cargo in Virus-Like Particles
The ability of virus shells to encapsulate a wide range of functional cargoes, especially multiple cargoes─siRNAs, enzymes, and chromophores─has made them an essential tool in biotechnology for advancing drug delivery applications and developing innovative new materials. Since therapeutic cargo may be formulated in different physical states (size, surface charge, etc.) we have investigated the spontaneous encapsulation of multiple, charged, small nanoparticles which repel when free in solution, inside a spherical cage formed of brome mosaic virus (BMV) coat proteins. Unlike the cases of coassembly of virus-like particles (VLPs) from multiple oligonucleotides and single nanoparticle cargo, the structure of virus-like particles thus obtained is consistent with that of the native icosahedral BMV capsid. Working with small metal nanoparticles as cargo allowed the pathway of assembly to be followed by electron and liquid atomic force microscopy and cryoelectron tomography. Based on the structural identification of nanoparticle─BMV protein intermediates, we have found that multiple cargo encapsulation occurs in stages through a specific "assembly line" pathway that is different from the previously described in vitro assembly mechanisms of virus-like particles (VLP). We propose a model that explains the experimental findings, some of which will be important for delivery applications, for instance, the pronounced nanoparticle size selectivity in competition experiments where different nanoparticle sizes are present.
- 29 December 2025
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (7) , 5438-5451
An Assembly-Line Mechanism for In Vitro Encapsulation of Fragmented Cargo in Virus-Like Particles
The ability of virus shells to encapsulate a wide range of functional cargoes, especially multiple cargoes─siRNAs, enzymes, and chromophores─has made them an essential tool in biotechnology for advancing drug delivery applications and developing innovative new materials. Since therapeutic cargo may be formulated in different physical states (size, surface charge, etc.) we have investigated the spontaneous encapsulation of multiple, charged, small nanoparticles which repel when free in solution, inside a spherical cage formed of brome mosaic virus (BMV) coat proteins. Unlike the cases of coassembly of virus-like particles (VLPs) from multiple oligonucleotides and single nanoparticle cargo, the structure of virus-like particles thus obtained is consistent with that of the native icosahedral BMV capsid. Working with small metal nanoparticles as cargo allowed the pathway of assembly to be followed by electron and liquid atomic force microscopy and cryoelectron tomography. Based on the structural identification of nanoparticle─BMV protein intermediates, we have found that multiple cargo encapsulation occurs in stages through a specific "assembly line" pathway that is different from the previously described in vitro assembly mechanisms of virus-like particles (VLP). We propose a model that explains the experimental findings, some of which will be important for delivery applications, for instance, the pronounced nanoparticle size selectivity in competition experiments where different nanoparticle sizes are present.
- Open Access
- 19 July 2024
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 16 (33) , 15544-15557
Insights into the nucleation and growth of BiOCl nanoparticles by in situ X-ray pair distribution function analysis and in situ liquid cell TEM
Controlled BiOCl synthesis is hindered by its fast nucleation and growth. Our precursor allows BiOCl formation to be slowed to enable BiOCl formation to be investigated by in situ X-ray PDF and in situ liquid cell TEM.
- 19 July 2024
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 16 (33) , 15544-15557
Open AccessInsights into the nucleation and growth of BiOCl nanoparticles by in situ X-ray pair distribution function analysis and in situ liquid cell TEM
Controlled BiOCl synthesis is hindered by its fast nucleation and growth. Our precursor allows BiOCl formation to be slowed to enable BiOCl formation to be investigated by in situ X-ray PDF and in situ liquid cell TEM.